BioCryst Pharma (BCRX) – Analyst Ratings
-
JPMorgan Reinstates BioCryst Pharma (BCRX) at Overweight
-
RBC Capital Upgrades BioCryst Pharma (BCRX) to Outperform, 'Doc Survey Suggesting Good Orladeyo Metrics'
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to BCRX Stock Lookup